Home / Stock ratings / Healthcare Stocks / TMO
Stock rating · Measuring & Controlling Devices, Nec
Thermo Fisher Scientific, Inc. (TMO) Stock Rating & Analysis
As of October 6, 2026, MELANY rates Thermo Fisher Scientific, Inc. 65 out of 100 (Hold). Its highest factor score is catalyst setup at 100, and its lowest is valuation at 40.
MELANY ratingRated 2026-10-06TMO · composite score
About Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. As of year-end 2025 it operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (17% of sales), specialty diagnostic products (11%), life science solutions (23%), and lab products and services, which includes CRO services and makes up the remainder.
Rating as of 2026-10-06 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why TMO scores 65/100
TMO's 8 factor scores run from 40 to 100, and 3 of them sit above its composite of 65. Here is how TMO breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 23.8x, earnings growth accelerating
Margins, returns on capital, and balance-sheet strength.
- Gross margin 41%
Direction and relative strength of the recent share-price trend.
- Price +5.6% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Earnings in 15 days (strong beat history)
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
- Earnings in 15 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How TMO compares
As of October 7, 2026, Thermo Fisher Scientific, Inc. is tied for 14th of 20 in Healthcare Stocks, where the average score is 67.
Key risks for TMO
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Thermo Fisher Scientific, Inc. sits in the Healthcare sector theme, which MELANY currently rates 37/100 for strength. Theme strength feeds TMO's momentum and catalyst factors above.
Tracking TMO
Thermo Fisher Scientific, Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Add TMO to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.
How MELANY rates TMO
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Thermo Fisher Scientific, Inc.'s 65/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about TMO
Is Thermo Fisher Scientific, Inc. (TMO) a buy?
As of 2026-10-06, MELANY rated Thermo Fisher Scientific, Inc. Hold with a composite score of 65/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Thermo Fisher Scientific, Inc.'s MELANY score?
Thermo Fisher Scientific, Inc. (TMO) has a MELANY composite score of 65/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the TMO stock rating calculated?
MELANY scores TMO from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Thermo Fisher Scientific, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Thermo Fisher Scientific, Inc. (TMO) Hold with a composite of 65/100 as of 2026-10-06. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the TMO stock price forecast?
MELANY does not publish price targets or forecasts for TMO. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 65/100 across eight factors for Thermo Fisher Scientific, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is TMO stock overvalued or undervalued?
MELANY's valuation factor currently reads 40/100 for Thermo Fisher Scientific, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives TMO's read.
What price should I buy TMO at?
MELANY is not flagging a fresh entry for TMO at its current Hold rating, so there is no entry zone to publish right now. Add TMO to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.
What are the risks of buying TMO stock?
The top risks MELANY currently flags for Thermo Fisher Scientific, Inc.: Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Thermo Fisher Scientific, Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 55/100 for Thermo Fisher Scientific, Inc., and earnings track record, at 76/100. The 65/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will TMO stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 76/100 for TMO right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this TMO rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-06. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores TMO continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, TMO included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.